glp-1 drugs and high blood pressure tied to risks in certain patients, study finds 💉 GLP-1 Drugs: An Overview

New research to be presented at the European Congress on Obesity (ECO 2025) suggests that weight loss treatments using GLP-1 and dual GLP-1/GIP receptor agonists can lead to significant fat loss with minimal reduction in lean muscle mass

10 or 15 mg once weekly) vs Reduce to tirzepatide 5 mg once weekly vs Placebo for 52 weeks (randomized 3:3:2 at week 60) Primary outcome: Percent change in bodyweight from baseline to week 112 Results: Primary outcome (percent change in bodyweight at week 112): Tirzepatide MTD -21.9%, Tirzepatide 5 mg -16.6%, Placebo -9.9% (estimated treatment difference vs placebo -12.0% for MTD and -6.6% for 5 mg

Through genetic testing, she found out her phenotype is "Hungry Brain." She also found out she has Bardet-Biedl syndrome, a genetic disorder that predisposes her to eat too much

Clinically Validated Formula Includes Eriomin Lemon Flavonoids, Berberine, Beta Glucan, Cinnamon & more

Future research will investigate the impact of semaglutide on a broader range of neuroendocrine tumor models, including three-dimensional patient-derived tumor cultures

Exenatide and renal failure